Objective: We used quantitative genetic models to assess whether sleep duration modifies genetic and environmental influences on depressive symptoms. Method: Participants were 1,788 adult twins from 894 same-sex twin pairs (192 male and 412 female monozygotic [MZ] pairs, and 81 male and 209 female dizygotic [DZ] pairs] from the University of Washington Twin Registry. Participants self-reported habitual sleep duration and depressive symptoms. Data were analyzed using quantitative genetic interaction models, which allowed the magnitude of additive genetic, shared environmental, and non-shared environmental influences on depressive symptoms to vary with sleep duration. Results: Within MZ twin pairs, the twin who reported longer sleep duration reported fewer depressive symptoms (e c = -0.17, SE = 0.06, P < 0.05). There was a significant gene × sleep duration interaction effect on depressive symptoms (a' c = 0.23, SE = 0.08, P < 0.05), with the interaction occurring on genetic influences that are common to both sleep duration and depressive symptoms. Among individuals with sleep duration within the normal range (7-8.9 h/night), the total heritability (h 2 ) of depressive symptoms was approximately 27%. However, among individuals with sleep duration within the low (< 7 h/night) or high (≥ 9 h/night) range, increased genetic influence on depressive symptoms was observed, particularly at sleep duration extremes (5 h/night: h 2 = 53%; 10 h/night: h 2 = 49%). Conclusion: Genetic contributions to depressive symptoms increase at both short and long sleep durations.
INTRODUCTION
Depression and sleep are tightly intertwined. Insomnia and hypersomnia are disease-defining symptoms for major depressive disorder and sleep-wake disturbance is a risk factor for depression onset, recurrence, and severity.
1,2 Objectively measured sleep disturbances predict poor treatment outcomes in patients with depression; in particular, short sleep duration is a risk factor for poor depression treatment outcome.
3 Insufficient sleep is associated with suicidality, even after controlling for depression symptomology, sleepiness, and insomnia. 4, 5 High suicidality is associated with increased discrepancy between weekday and weekend sleep duration, a common metric of chronic sleep debt.
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The optimal amount of sleep needed to maintain physiological homeostasis is individualized and influenced by both genetic and environmental factors. The physiologically normal "sleep fraction" in humans is between 29% and 33% of the sleep-wake cycle, or 7 to 7.9 hours under conditions of environmental and temporal isolation. 6, 7 The heritability of sleep duration is between 31% and 55%, suggesting a substantial amount of sleep need is genetically determined, but environmental factors also contribute. [8] [9] [10] [11] Modern society, with its ubiquitous technology and countless competing interests for time, along with the zeitgeist deemphasizing sleep's importance, creates an environment that promotes sleep deprivation. 12 Currently, about one-third of the working population sleeps ≤ 6 hours per night. Over the past century, habitual sleep duration has dropped an estimated 1.5 to 2 hours per night. [13] [14] [15] Meanwhile, human physiological sleep need remains unchanged. This growing disconnect between sleep need and sleep actualization has substantial adverse consequences for cognitive functioning and metabolic, cardiovascular, immunological, and psychological health. 3, [16] [17] [18] [19] [20] [21] [22] This study examines the association between habitual sleep duration and depressive symptoms using a genetically informed twin design. Twins, if reared together, are identical in age and typically well matched for shared family background and numerous childhood and adolescent exposures. As such, twin comparisons can be used to control for third-variable confounders that typically differ among unrelated individuals. This approach is particularly helpful when investigating the relationship between sleep duration and depression because many subjective and objective aspects of these phenotypes are genetically influenced. 23, 24 Twin studies can also be used to estimate gene × environment interaction (G×E) effects. In the current paper, we examine sleep duration as an "environmental" moderator of the heritability of depressive symptoms, while also modeling genetic influences on habitual sleep duration. Previous studies suggest age, gender, and depression recurrence influence the heritability of major depressive disorder by way of G×E effects. 25 Therefore, the goal of the current study was to: (1) determine the magnitude of genetic and environmental influences on sleep duration and depressive symptoms, and (2) determine if sleep duration moderates genetic influences on depressive symptoms.
METHODS

Participants
The University of Washington Twin Registry is a communitybased sample of twins constructed using data from the Washington State Department of Licensing. The minimum age for participation is 18 years. As of September 2013, the Registry consisted of over 8,000 pairs. Zygosity is determined using previously validated self-report methods that are correct ≥ 95% of the time. 26, 27 Every twin enrolled in the Registry completes a recruitment survey. In 2006 and 2008, an additional health survey was mailed to more than 4,000 enrolled twins that included sleep duration and depression symptom questions. Since 2009, the recruitment survey has included the same questions. The data collection procedures were approved by the University of Washington Institutional Review Board. All twins were raised together.
Measures
Sleep Duration
Habitual sleep duration was obtained from responses to the question, "On average, how long do you sleep per night?" reported in hours and minutes. For the purposes of our calculations we categorized sleep duration into 3 groups. Normal sleep duration was considered 7-8.9 h because this range encompasses the physiologically normal sleep fraction in humans 6, 7 and the sleep duration considered normal in previous studies.
28 -30 We classified sleep duration of < 7 h per night as short sleep and ≥ 9 h per night as long sleep. One exception to these definitions involves our calculation of heritability. Heritability estimates are generated from model parameters that require a single number. Therefore, we defined normal sleep as 8 h/night, short sleep as 5 h/night, and long sleep as 10 h/night for these specific calculations.
Depressive Symptoms
Depressive symptoms were measured using participants' self-report on the modified 3 question Patient Health Questionnaire-9 (mPHQ-9), which asks "In the past 4 weeks, how often have you been bothered by the following problems": Little interest or pleasure in doing things; Feeling down, depressed, hopeless; and Feeling tired or having little energy. All items were rated on a 4-point Likert scale ranging from 0 = Not at all to 3 = Nearly every day. Responses were summed to yield depressive symptom scores (range = 0 to 9; mean = 1.71; standard deviation (SD) = 1.82; 25 th -75 th percentile = 0 to 3). As described below in the section labeled "Sensitivity Analysis," we also conducted a complimentary analysis that omitted the item referring to "feeling tired or having little energy."
Sociodemographics
Age, sex, and race were self-reported. Race was dichotomized into Caucasian and non-Caucasian (American Indian, Alaska Native, Native Hawaiian, Pacific Islander, Asian, Black or African American, or other) categories. Education was ascertained by the question, "What is the highest level of school you have completed?" A total of 7 responses were possible, ranging from "eighth grade or less" to "graduate or professional degree." The midpoint was "some college, but no degree or certificate."
Statistical Analyses
We began by examining zygosity specific twin pair correlations for sleep duration and depressive symptoms. The withintrait, cross-twin correlations (e.g., the correlation between sleep duration in Twin A and sleep duration in Twin B) can be used to evaluate the magnitude of genetic and environmental influences on a given phenotype, while the cross-trait, crosstwin correlations (e.g., the correlation between sleep duration in Twin A and depressive symptoms in Twin B) can be used to evaluate the extent to which the association between sleep duration and depressive symptoms is accounted for by genetic versus environmental pathways.
Next we evaluated these questions more formally with quantitative genetic models using the software program Mplus (Muthén & Muthén, 1998 -2012 . This approach allows modeling of genetic overlap and moderation effects between sleep duration and depressive symptoms. First, we fit a bivariate twin model, shown in Figure 1 . Total variance in each of the observed phenotypes (the boxes labeled "Sleep Duration" and "Depressive Symptoms") was decomposed into 3 latent factors: additive genetic influences (A), shared environmental influences (i.e., environmental influences that make siblings similar to one another, or C), and non-shared environmental influences (i.e., environmental influences that are unique to each twin, plus measurement error, or E). The ACE components for each phenotype were standardized (mean = 0, SD = 1) and the paths from the ACE components to the phenotype were estimated. The correlation between additive genetic influences (A) in the first and second member of each twin pair was fixed to 1.0 in monozygotic (MZ) twins and 0.5 in dizygotic (DZ) twins, consistent with genetic theory. The correlation between common environmental (C) factors was fixed to 1.0 in all pair types, whereas the correlation between unique environmental (E) factors was fixed to 0 in all pair types. Finally, depressive symptoms were regressed on the ACE components of sleep duration. These cross paths estimate the extent to which genetic and environmental influences on sleep duration also influence depressive symptoms. Previous authors have described the logic and parameterization of twin models in great detail. 31 We fit an extension of the bivariate twin model that examined the interaction between sleep duration and the genetic influences on depressive symptoms. As illustrated in Figure 2 , this interaction model allows the genetic and environmental cross paths between sleep duration and depressive symptoms (pathways labeled: a c + a' c *sleep; c c + c' c *sleep; and e c + e' c *sleep), as well as the residual genetic and environmental variation in depressive symptoms (pathways labeled: a d + a' d *sleep; c d + c' d *sleep; and e d + e' d *sleep), to vary as a function of habitual sleep duration. Note that the cross paths between the ACE components of sleep duration and depressive symptoms represent genetic and environmental influences on depressive symptoms that are shared with (common to) sleep duration, whereas the ACE components of depressive symptoms represent genetic and environmental influences unique to depressive symptoms. Further explanation about using variance components for testing gene-environment interactions are explained in detail elsewhere.
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RESULTS
The study sample includes 1,788 individuals from 894 same-sex twin pairs (604 monozygotic [MZ], 290 dizygotic [DZ]). Sample characteristics are summarized in Table 1 . Overall, the sample was composed of younger adults (mean = 36.1 years), who were welleducated (42% with a college degree or higher), predominantly Caucasian (88%), and female (69%). The most common twin relationship was female-female MZ pairs (46%). The mean sleep duration in the sample was in the normal range (mean = 7.17 h). Most participants (n = 1,186, 66%) reported "normal" sleep duration (7-8.9 h), while 24% (n = 434) reported "short" sleep (< 7 h) and 9% (n = 166) reported "long" sleep (≥ 9 h).
Sleep duration was negatively correlated with depressive symptoms (r = -0.16, P < 0.001). As shown in Figure 3 , 
What are the Magnitudes of Genetic and Environmental Influences on Sleep Duration and Depressive Symptoms?
The within-trait and cross-trait twin correlations for sleep duration and depressive symptoms are summarized in Table 2 . The MZ correlation for sleep duration (0.36, 95% CI 0.29-0.43) substantially exceeded the DZ correlation (0.14, 95% CI 0.02-0.25), suggesting that familial resemblance in sleep duration was primarily due to genetic influences, with minimal contribution of the shared environment. As expected, the MZ correlation for depressive symptoms (0.31, 95% CI 0.23-0.38) exceeded the DZ correlation (0.23, 95% CI 0.11-0.33), consistent with a genetic contribution to variance in depression. (The significance of the MZ-DZ differences was formally tested with the quantitative genetic models, described below.) Finally, the cross-trait, cross-twin correlations were negligible (and not significantly different than zero) in either MZ or DZ twins. That is, twin A's sleep duration was unrelated to twin B's depressive symptoms (for comparison, the phenotypic correlation between sleep duration and depressive symptoms was -0.11, P < 0.01). These results suggest genetic influences on sleep duration do not account for the association between sleep duration and depressive symptoms.
These initial results were investigated more formally with quantitative genetic models. The bivariate model (Model 1, Table 3 , illustrated in Figure 1 ) fit the data well (χ 2 = 43.87, df = 35, P = 0.15, RMSEA = 0.024, CFI = 0.956, see footnote A). 33 In addition to the full bivariate model, we also fit a reduced bivariate model (Model 2, Table 3 ), in which the shared environmental variance (c s pathway) in sleep duration and the shared environmental pathway between sleep duration and depressive symptoms (c c pathway) were fixed to zero. This reduced model also fit the data well (χ 2 = 44.68, df = 37, P = 0.18, CFI = 0.962, RMSEA = 0.022), and the change in model fit was not significant (Δχ 2 = 0.81, Δdf = 2, P = 0.67). Consequently, these parameters were fixed to zero in all subsequent models.
Unstandardized parameter estimates from Model 2 are summarized in Table 3 . There were 2 ) = 0.17], 13% to shared environmental factors, and the rest (70%) to non-shared environmental factors.
Does Sleep Duration Moderate Genetic Influence on Depressive Symptoms?
Unstandardized parameter estimates from Model 3 are summarized in Table 3 . We found evidence for a signifi cant interaction between sleep duration and the genetic crosspath from sleep duration to depressive symptoms (a' c = 0.23, SE = 0.08, P < 0.05). There were no signifi cant interactions on the unique variance components for depressive symptoms (parameters a' d , c' d , and e' d ). That is, the genes that were not shared with sleep duration were also not moderated by sleep duration; it was the shared genetic mechanism (genes that overlap between sleep duration and depressive symptoms) that became more infl uential as individuals diverged from normal sleep. Consequently, we fi t a reduced model (Model 4) that fi xed the interaction terms on the unique variance components to zero. Results from Model 4 are illustrated in Figure 4 . Genetic infl uences on depressive symptoms were greater among individuals with either high or low sleep duration. That is, as sleep duration diverges from normal (7-8.9 h/night), genetic vulnerabilities common to both sleep duration and depressive symptoms become more infl uential.
To further illustrate these results, we calculated the modelimplied heritability of depressive symptoms for individuals with habitual sleep durations of 8 h/night (within our defi ned range of normal sleep), 5 h/night (within our defi ned range of short sleep), and 10 h/night (within our defi ned range of long sleep). Among individuals sleeping 8 h/night, the total heritability of depressive symptoms was approximately 27% (95% CI 0% to 58%). However, among individuals with short or long sleep duration we observed increased genetic infl uence on depressive symptoms, particularly at sleep duration extremes (5 h/night: h 2 = 53% [95% CI 31% to 75%]; 10 h/night: h 2 = 49% [95% CI 26% to 72%]). Therefore sleep durations outside the normal range increased the genetic risk for depressive symptoms.
Sensitivity Analysis
Because our depressive symptoms measure, the mPHQ-9, included an item that referred to "feeling tired or having little energy," we conducted a sensitivity analysis that omitted this item from the mPHQ-9 sum score. Notably, the pattern of results was unchanged: there was a signifi cant interaction between the genetic cross-path and sleep duration (a' c = 0.13, SE = 0.5, P = 0.01), resulting in U-shaped curve, with stronger genetic effects at both short and long sleep durations. Moreover, the interaction between sleep duration and genetic infl uences unique to depression remained nonsignifi cant (a' d = 0.01, SD = 0.18, P = 0.96).
DISCUSSION
We found that genetic infl uences on depressive symptoms were moderated by habitual sleep duration. Both short and long sleep extremes were associated with the highest heritability of depressive symptoms. As sleep duration moved away from the extremes and toward the "normal" range, the effect of the nonshared environment was more strongly associated with depressive symptoms, while genetic factors became less important. These fi ndings show a gene-environment interaction between sleep duration and depressive symptoms.
Although our study does not specify the shared genetic factors that drive this interaction, recent fi ndings suggest candidate genes and pathways. The CLOCK gene encodes a transcription factor that infl uences both the persistence and period of circadian rhythms and variants in the human CLOCK gene are associated with sleep duration. [36] [37] [38] A point mutation in DEC2, a gene that regulates both CLOCK and another circadian gene ARNTL, is associated with short habitual sleep duration. 39 ARNTL, in turn, encodes a protein that heterodimerizes with CLOCK creating a complex that activates circadian rhythm associated genes including PER1 and is associated with sleep and wake onset times. 37 ARNTL, PER2, and NPAS2 form a functional unit in the circadian system and polymorphisms in these genes are associated with seasonal affective disorder. 40 The gene ABCC9 encodes an ATP-sensitive potassium channel and a recent GWAS study identifi ed a polymorphism in this gene that explained 5% of the variance in usual sleep duration. 41 Variants in ABCC9 have also been found to be associated with depressive symptoms. 42 Polymorphisms in 5-hydroxytryptamine Additive Genetic Shared Environmental Non-Shared Environmental transporter linked polymorphic region (5-HTTLPR) are associated with clinical response to sleep deprivation in bipolar depression 43 and short sleep with higher depressed mood in young adults. 44 Taken together these studies suggest that genes related to circadian rhythms, coupling of cell metabolism to electrical activity, and serotonergic neurotransmission may be central to the gene/environment interaction we report in this study.
Sleep deprivation, either total or partial, has long been considered a treatment option for depression. [45] [46] [47] [48] [49] Approximately 46% to 70% of depressed patients respond to sleep deprivation, with improvement observed for all signs and symptoms of major depressive disorder. 45 However, the therapeutic response is usually temporary, lasting no more than several days, with the vast majority eventually relapsing and some experiencing worsening of their depression. [50] [51] [52] Further, sleep reduction can provoke manic or hypomanic episodes in predisposed patients. 53 At present, there is no convincing mechanism explaining the therapeutic benefits of sleep deprivation, although a number of hypotheses have been proposed including effects on: homeostatic sleep drive, 54 cerebral adenosine concentrations, 55 and synaptic monoamines-particularly serotonin and dopamine. 43, 44, [56] [57] [58] In contrast, the long term effects of habitual short sleep are well-established and include adverse endocrine, 59 immune, and reduced longevity. 77 These factors, along with our current findings, raise questions about the value of sleep curtailment as a depression treatment. Alternatively, our study suggests that normalization of sleep duration may reduce genetic risk for depressive symptoms allowing greater influence of environmental factors, such as psychotherapy, on mood. The therapeutic implications of this finding deserve further research.
The "normal" amount of sleep for any individual is age dependent and determined by the amount required to maintain physiological homeostasis and daytime alertness. Studies of humans in environmental isolation suggest 7 to 9 hours per night encompasses normal sleep for the majority of individuals. 6, 7 This range also includes the amount of sleep considered normal in numerous epidemiological studies assessing the untoward effect of short sleep. 10, 17, 21, 77 Because about a third of sleep need is heritable, 11 with substantial variability from person to person, the precise amount of sleep needed for optimal health and functioning is best determined by the individual. This would be ascertained by the amount of sleep calculated from bedtime to natural wake time following a period of sleep saturation.
Both insomnia and insufficient sleep represent short sleep, but are physiologically distinct entities. Those with insomnia "can't sleep," while those with insufficient sleep "won't sleep." When compared to healthy controls, insomnia patients have higher scores on the multiple sleep latency test, 78 an objective measure of sleep-ability where subjects are given four to five opportunities to take a 20-minute nap during the day generating a mean sleep latency score in minutes. This, along with the fact that insomnia patients may misperceive sleep for wakefulness makes insomnia a state of hyperarousal with decreased sleep drive. 79, 80 In contrast, both acute and chronic sleep deprivation decreases scores on the multiple sleep latency test. 81 Therefore, the short sleep of insomnia, a common symptom of depression, is physiologically distinct from the short sleep of sleep deprivation. We did not assess insomnia as a covariate in our analysis, but these distinctions suggest that future studies should assess if insomnia modifies the gene by environment interaction between short sleep and depressive symptoms.
Our study has several limitations. Our twins were predominantly younger adult Caucasian women, and therefore our results should be applied to the general population with caution.
In particular, future research should examine the relation between sleep and depressive symptoms in racial/ethnic minorities. It should be noted that our sample was derived from the community and not from a clinical population seeking healthcare. Self-reported sleep duration and depressive symptoms are commonly used in observational studies but can be problematic. However, the PHQ-9, from which the mPHQ-9 was derived for this study, is accurate as a screening instrument for depression, 82, 83 and self-reported sleep duration approximates objective measures of sleep length, 84, 85 although recent studies suggest it may be biased by overestimation. 86 Future studies assessing gene-environment interactions between sleep duration and depression would benefit from direct objective measures or related endophenotype quantification.
In conclusion, this is the first study to demonstrate a gene by environment interaction between habitual sleep duration and depressive symptoms. Both short (< 7 h/night) and long (≥ 9 h/ night) sleep increased the heritability of depressive symptoms, suggesting genetic risk for depressive symptoms increases as twins move away from normal sleep duration (7-8.9 h/night). This works suggests that environmentally mediated treatments for depression may have the greatest opportunity for success when administered in a patient sleeping normal amounts of time. Future research should consider the effects of habitual sleep duration on treatment success. 
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